In this study, we found that METTL3 is up-regulated in lung cancer, and overexpressed METTL3 mediates m6A modification of LCAT, leading to its stabilization, thus providing molecular insight for LCAT3 overexpression in LUAD. Here, METTL3 is linked to lung carcinoma.